Histologic progression of acne inversa/hidradenitis suppurativa: Implications for future investigations and therapeutic intervention
dc.contributor.author | Dunstan, Robert W. | |
dc.contributor.author | Salte, Katherine M. | |
dc.contributor.author | Todorović, Viktor | |
dc.contributor.author | Lowe, Margaret | |
dc.contributor.author | Wetter, Joseph B. | |
dc.contributor.author | Harms, Paul W. | |
dc.contributor.author | Burney, Richard E. | |
dc.contributor.author | Scott, Victoria E. | |
dc.contributor.author | Smith, Kathleen M. | |
dc.contributor.author | Rosenblum, Michael D. | |
dc.contributor.author | Gudjonsson, Johann E. | |
dc.contributor.author | Honore, Prisca | |
dc.date.accessioned | 2021-07-01T20:12:32Z | |
dc.date.available | 2022-07-01 16:12:31 | en |
dc.date.available | 2021-07-01T20:12:32Z | |
dc.date.issued | 2021-06 | |
dc.identifier.citation | Dunstan, Robert W.; Salte, Katherine M.; Todorović, Viktor ; Lowe, Margaret; Wetter, Joseph B.; Harms, Paul W.; Burney, Richard E.; Scott, Victoria E.; Smith, Kathleen M.; Rosenblum, Michael D.; Gudjonsson, Johann E.; Honore, Prisca (2021). "Histologic progression of acne inversa/hidradenitis suppurativa: Implications for future investigations and therapeutic intervention." Experimental Dermatology (6): 820-830. | |
dc.identifier.issn | 0906-6705 | |
dc.identifier.issn | 1600-0625 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/168326 | |
dc.description.abstract | Since first recognized in 1839, the pathogenesis of acne inversa (AI) has undergone repeated revisions. Although there is agreement that AI involves occlusion of hair follicles with subsequent inflammation and the formation of tracts, the histologic progression of this disease still requires refinement. The objective of this study was to examine the histologic progression of AI based on the examination of a large cohort of punch biopsies and excisional samples that were examined first by hematoxylin and eosin staining. The most informative of these samples were step- sectioned and stained by immunohistochemistry for epithelial and inflammatory markers. Based on this examination, the following observations were made: 1) AI arises from the epithelium of the infundibulum of terminal and vellus hairs; 2) These form cysts and epithelial tendrils that extend into soft tissue; 3) Immunohistochemical staining demonstrates the epithelium of AI is disordered with infundibular and isthmic differentiation and de novo expression of stem cell markers; 4) The inflammatory response in AI is heterogeneous and largely due to cyst rupture. The conclusions of this investigation were that AI is an epithelial- driven disease caused by infiltrative, cyst forming tendrils and most of the inflammation is due to cyst rupture and release of cornified debris and bacteria. Cyst rupture often occurs below the depths of punch biopsy samples indicating their use for analysis may give an incomplete picture of the disease. Finally, our data suggest that unless therapies inhibit tendril development, it is unlikely they will cause prolonged treatment- induced remission in AI. | |
dc.publisher | Wiley Periodicals, Inc. | |
dc.publisher | Springer | |
dc.subject.other | pathogenesis | |
dc.subject.other | hair follicle | |
dc.subject.other | diseases | |
dc.subject.other | Hidradenitis suppurativa | |
dc.subject.other | inflammatory skin | |
dc.title | Histologic progression of acne inversa/hidradenitis suppurativa: Implications for future investigations and therapeutic intervention | |
dc.type | Article | |
dc.rights.robots | IndexNoFollow | |
dc.subject.hlbsecondlevel | Dentistry | |
dc.subject.hlbtoplevel | Health Sciences | |
dc.description.peerreviewed | Peer Reviewed | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/168326/1/exd14273_am.pdf | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/168326/2/exd14273.pdf | |
dc.identifier.doi | 10.1111/exd.14273 | |
dc.identifier.source | Experimental Dermatology | |
dc.identifier.citedreference | Melnik BC, Plewig G. Impaired Notch- MKP- 1 signalling in hidradenitis suppurativa: an approach to pathogenesis by evidence from translational biology. Exp Dermatol. 2013; 22 ( 3 ): 172 - 177. | |
dc.identifier.citedreference | Poli F, Wolkenstein P, Revuz J. Back and face involvement in hidradenitis suppurativa. Dermatology. 2010; 221 ( 2 ): 137 - 141. | |
dc.identifier.citedreference | Frew JW, Hawkes JE, Krueger JG. A systematic review and critical evaluation of immunohistochemical associations in hidradenitis suppurativa. F1000 Res. 2018; 7: 1923. | |
dc.identifier.citedreference | Plewig G, Kligman AM. The Anatomy of Follicles. Acne and Rosacea. Berlin, Heidelberg (Eds: G Plewig, AM Kligman ): Springer; 2000: 30 - 49. | |
dc.identifier.citedreference | Panteleyev AA. Functional anatomy of the hair follicle: the secondary hair germ. Exp Dermatol. 2018; 27 ( 7 ): 701 - 720. | |
dc.identifier.citedreference | Schneider MR, Paus R. Deciphering the functions of the hair follicle infundibulum in skin physiology and disease. Cell Tis Res. 2014; 358 ( 3 ): 697 - 704. | |
dc.identifier.citedreference | Amoh Y, Kanoh M, Niiyama S, et al. Human and mouse hair follicles contain both multipotent and monopotent stem cells. Cell Cycle. 2009; 8 ( 1 ): 176 - 177. | |
dc.identifier.citedreference | Yang L, Zhang S, Wang G. Keratin 17 in disease pathogenesis: from cancer to dermatoses. J Pathol. 2019; 247 ( 2 ): 158 - 165. | |
dc.identifier.citedreference | Commo S, Gaillard O, Bernard BA. The human hair follicle contains two distinct K19 positive compartments in the outer root sheath: a unifying hypothesis for stem cell reservoir? Differentiation. 2000; 66 ( 4- 5 ): 157 - 164. | |
dc.identifier.citedreference | Kanoh M, Amoh Y, Sato Y, Katsuoka K. Expression of the hair stem cell- specific marker nestin in epidermal and follicular tumors. Eur J Dermatol. 2008; 18 ( 5 ): 518 - 523. | |
dc.identifier.citedreference | Li L, Mignone J, Yang M, et al. Nestin expression in hair follicle sheath progenitor cells. Proc Natl Acad Sci. 2003; 100 ( 17 ): 9958 - 9961. | |
dc.identifier.citedreference | Bose A, Teh MT, Mackenzie I, Waseem A. Keratin K15 as a biomarker of epidermal stem cells. Inter J Mol Sci. 2013; 14 ( 10 ): 19385 - 19398. | |
dc.identifier.citedreference | Welch DR, Hurst DR. Beyond the primary tumor: progression, invasion, and metastasis. In: The Molecular Basis of Human Cancer. New York, NY: Humana Press; 2017: 203 - 216. | |
dc.identifier.citedreference | Maru GB, Gandhi K, Ramchandani A, Kumar G. The role of inflammation in skin cancer. In: Inflammation and Cancer. Basel, Switzerland: Springer; 2014: 437 - 469. | |
dc.identifier.citedreference | Selmer J, Skov T, Spelman L, Weedon D. Squamous cell carcinoma and keratoacanthomas are biologically distinct and can be diagnosed by light microscopy: a review. Histopathology. 2016; 69 ( 4 ): 535 - 541. | |
dc.identifier.citedreference | Ackerman AB. Differentiation of benign from malignant neoplasms by silhouette. Am J Dermatopath. 1989; 11 ( 4 ): 297 - 300. | |
dc.identifier.citedreference | Zouboulis CC, Desai N, Emtestam L, et al. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa. J Euro Acad Dermatol Venereol. 2015; 29 ( 4 ): 619 - 644. | |
dc.identifier.citedreference | Burney RE. 35- year experience with surgical treatment of hidradenitis suppurativa. World J Surg. 2017; 41 ( 11 ): 2723 - 2730. | |
dc.identifier.citedreference | Kohorst JJ, Baum CL, Otley CC, et al. Surgical management of hidradenitis suppurativa: outcomes of 590 consecutive patients. Dermatol Surg. 2016; 42 ( 9 ): 1030 - 1040. | |
dc.identifier.citedreference | Lavogiez C, Delaporte E, Darras- Vercambre S, et al. Clinicopathological study of 13 cases of squamous cell carcinoma complicating hidradenitis suppurativa. Dermatology. 2010; 220 ( 2 ): 147 - 153. | |
dc.identifier.citedreference | Lee CN, Chen W, Hsu CK, Weng TT, Lee JY, Yang CC. Dissecting folliculitis (dissecting cellulitis) of the scalp: a 66- patient case series and proposal of classification. J Dtsch Dermatol Ges. 2018; 16 ( 10 ): 1219 - 1226. | |
dc.identifier.citedreference | Badaoui A, Reygagne P, Cavelier- Balloy B, et al. Dissecting cellulitis of the scalp: a retrospective study of 51 patients and review of literature. Br J Dermatol. 2016; 174 ( 2 ): 421 - 423. | |
dc.identifier.citedreference | BrÄ niÅ teanu DE, Molodoi A, Ciobanu D, et al. The importance of histopathologic aspects in the diagnosis of dissecting cellulitis of the scalp. Rom J Morphol Embryol. 2009; 50 ( 4 ): 719 - 724. | |
dc.identifier.citedreference | Deckers IE, Benhadou F, Koldijk MJ, et al. Inflammatory bowel disease is associated with hidradenitis suppurativa: results from a multicenter cross- sectional study. J Am Acad Dermatol. 2017; 76 ( 1 ): 49 - 53. | |
dc.identifier.citedreference | Jørgensen AH, Thomsen SF, Karmisholt KE, Ring HC. Clinical, microbiological, immunological and imaging characteristics of tunnels and fistulas in hidradenitis suppurativa and Crohn- s disease. Exp Dermatol. 2020; 29 ( 2 ): 118 - 123. | |
dc.identifier.citedreference | Tozer PJ, Lung P, Lobo AJ, et al. Pathogenesis of Crohn’s perianal fistula- understanding factors impacting on success and failure of treatment strategies. Aliment Pharm Ther. 2018; 48 ( 3 ): 260 - 269. | |
dc.identifier.citedreference | Frew JW, Hawkes JE, Krueger JG. A systematic review and critical evaluation of inflammatory cytokine associations in hidradenitis suppurativa. F1000 Res. 2018; 7: 1930. | |
dc.identifier.citedreference | Schlapbach C, Hänni T, Yawalkar N, Hunger RE. Expression of the IL- 23/Th17 pathway in lesions of hidradenitis suppurativa. J Am Acad Dermatol. 2011; 65 ( 4 ): 790 - 798. | |
dc.identifier.citedreference | Lima AL, Karl I, Giner T, et al. Keratinocytes and neutrophils are important sources of proinflammatory molecules in hidradenitis suppurativa. Br J Dermatol. 2016; 174 ( 3 ): 514 - 521. | |
dc.identifier.citedreference | Burgess DJ. Spatial transcriptomics coming of age. Nat Rev Genet. 2019; 20 ( 6 ): 317. | |
dc.identifier.citedreference | Saha S, Matthews DA, Bessant C. High throughput discovery of protein variants using proteomics informed by transcriptomics. Nucleic Acids Res. 2018; 46 ( 10 ): 4893 - 4902. | |
dc.identifier.citedreference | Theut Riis P, Thorlacius LR, Jemec GB. Investigational drugs in clinical trials for hidradenitis suppurativa. Expert Opin Investig Drug. 2018; 27 ( 1 ): 43 - 53. | |
dc.identifier.citedreference | Kimball AB, Okun MM, Williams DA, et al. Two phase 3 trials of adalimumab for hidradenitis suppurativa. N Engl J Med. 2016; 375 ( 5 ): 422 - 434. | |
dc.identifier.citedreference | Ring HC, Sigsgaard V, Thorsen J, et al. The microbiome of tunnels in hidradenitis suppurativa patients. J Euro Acad Dermatol and Venereol. 2019; 33 ( 9 ): 1775 - 1780. | |
dc.identifier.citedreference | Chen WT, Chi CC. Association of hidradenitis suppurativa with inflammatory bowel disease: A systematic review and meta- analysis. JAMA Dermatol. 2019; 155 ( 9 ): 1022 - 1027. | |
dc.identifier.citedreference | Hoffman LK, Ghias MH, Garg A, Hamzavi IH, Alavi A, Lowes MA. Major gaps in understanding and treatment of hidradenitis suppurativa. Semin Cutan Med Surg. 2017; 36 ( 2 ): 86 - 92. | |
dc.identifier.citedreference | Ralf Paus L, Kurzen H, Kurokawa I, et al. What causes hidradenitis suppurativa? Exp Dermatol. 2008; 17 ( 5 ): 455 - 456. | |
dc.identifier.citedreference | Alikhan A, Lynch PJ, Eisen DB. Hidradenitis suppurativa: a comprehensive review. J Am Acad Dermatol. 2009; 60 ( 4 ): 539 - 561. | |
dc.identifier.citedreference | Yu Ca C- W, Cook MG. Hidradenitis suppurativa: a disease of follicular epithelium, rather than apocrine glands. Br J of Dermatol. 1990; 122 ( 6 ): 763 - 769. | |
dc.identifier.citedreference | Prens E, Deckers I. Pathophysiology of hidradenitis suppurativa: an update. J Am Acad Dermatol. 2015; 73 ( 5 ): S8 - S11. | |
dc.identifier.citedreference | Sellheyer K, Krahl D. - Hidradenitis suppurativa- is acne inversa! An appeal to (finally) abandon a misnomer. Int J Dermatol. 2004; 7: 535 - 540. | |
dc.identifier.citedreference | Laffert MV, Helmbold P, Wohlrab J, Fiedler E, Stadie V, Marsch WC. Hidradenitis suppurativa (acne inversa): early inflammatory events at terminal follicles and at interfollicular epidermis. Exp Dermatol. 2010; 19 ( 6 ): 533 - 537. | |
dc.identifier.citedreference | Pink A, Anzengruber F, Navarini AA. Acne and hidradenitis suppurativa. Br J Dermatol. 2018; 178 ( 3 ): 619 - 631. | |
dc.identifier.citedreference | Chen W, Plewig G. Should hidradenitis suppurativa/acne inversa best be renamed as - dissecting terminal hair folliculitis- ? Exp Dermatol. 2017; 26 ( 6 ): 544 - 547. | |
dc.identifier.citedreference | Boer J, Weltevreden EF. Hidradenitis suppurativa or acne inversa. A clinicopathological study of early lesions. Br J Dermatol. 1996; 135 ( 5 ): 721 - 725. | |
dc.identifier.citedreference | Danby FW, Jemec GB, Marsch WC, Von Laffert M. Preliminary findings suggest hidradenitis suppurativa may be due to defective follicular support. Br J Dermatol. 2013; 168 ( 5 ): 1034 - 1039. | |
dc.identifier.citedreference | Fismen S, Ingvarsson G, Moseng D, et al. A clinical- pathological review of hidradenitis suppurativa: using immunohistochemistry one disease becomes two. Apmis. 2012; 120 ( 6 ): 433 - 440. | |
dc.identifier.citedreference | Jemec GB, Hansen U. Histology of hidradenitis suppurativa. J Am Acad Dermatol. 1996; 34 ( 6 ): 994 - 999. | |
dc.identifier.citedreference | Jemec GB, Thomsen BM, Hansen U. The homogeneity of hidradenitis suppurativa lesions: a histological study of intra- individual variation. APMIS. 1997; 105 ( 1- 6 ): 378 - 383. | |
dc.identifier.citedreference | Kamp S, Fiehn AM, Stenderup K, et al. Hidradenitis suppurativa: a disease of the absent sebaceous gland? Sebaceous gland number and volume are significantly reduced in uninvolved hair follicles from patients with hidradenitis suppurativa. Br J Dermatol. 2011; 164 ( 5 ): 1017 - 1022. | |
dc.identifier.citedreference | Kurokawa I, Nishijima S, Kusumoto K, Senzaki H, Shikata N, Tsubura A. Immunohistochemical study of cytokeratins in hidradenitis suppurativa (acne inversa). Int J Med Res. 2002; 30 ( 2 ): 131 - 136. | |
dc.identifier.citedreference | Kurzen H, Jung EG, Hartschuh W, Moll I, Franke WW, Moll R. Forms of epithelial differentiation of draining sinus in acne inversa (hidradenitis suppurativa). Br J Dermatol. 1999; 141 ( 2 ): 231 - 239. | |
dc.identifier.citedreference | Lafferty MV, Helmbold P, Wohlrab J, Fiedler E, Stadie V, Marsch WC. Hidradenitis suppurativa (acne inversa): early inflammatory events at terminal follicles and at interfollicular epidermis. Exp Dermatol. 2010; 19 ( 6 ): 533 - 537. | |
dc.identifier.citedreference | Saunte DM, Jemec GB. Hidradenitis suppurativa: advances in diagnosis and treatment. JAMA. 2017; 318 ( 20 ): 2019 - 2032. | |
dc.identifier.citedreference | Van der Zee HH, De Ruiter L, Boer J, et al. Alterations in leucocyte subsets and histomorphology in normal- appearing perilesional skin and early and chronic hidradenitis suppurativa lesions. Br J Dermatol. 2012; 166 ( 1 ): 98 - 106. | |
dc.identifier.citedreference | van der Zee HH, Laman JD, Boer J, Prens EP. Hidradenitis suppurativa: viewpoint on clinical phenotyping, pathogenesis and novel treatments. Exp Dermatol. 2012; 21 ( 10 ): 735 - 739. | |
dc.identifier.citedreference | von Laffert M, Stadie V, Wohlrab J, Marsch WC. Hidradenitis suppurativa/acne inversa: bilocated epithelial hyperplasia with very different sequelae. Br J Dermatol. 2011; 164 ( 2 ): 367 - 371. | |
dc.identifier.citedreference | Vossen AR, van der Zee HH, Prens EP. Hidradenitis Suppurativa: a systematic review integrating inflammatory pathways into a cohesive pathogenic model. Front Immunol. 2018; 9: 1 - 12. | |
dc.identifier.citedreference | Kurokawa I, Jemec GB, et al. What causes hidradenitis suppurativa? Viewpoint 4. Exp Dermatol. 2008; 17 ( 5 ): 462 - 465. | |
dc.identifier.citedreference | Smith MK, Nicholson CL, Parks- Miller A, Hamzavi IH. Hidradenitis suppurativa: an update on connecting the tracts. F1000Res. 2017; 6: 1272. | |
dc.identifier.citedreference | Boer J, Jemec GB. Mechanical stress and the development of pseudo- comedones and tunnels in Hidradenitis suppurativa/Acne inversa. Exp Dermatol. 2016; 25 ( 5 ): 396 - 397. | |
dc.identifier.citedreference | Gniadecki R, Jemec GB. Lipid raft- enriched stem cell- like keratinocytes in the epidermis, hair follicles and sinus tracts in hidradenitis suppurativa. Exp Dermatol. 2004; 13 ( 6 ): 361 - 363. | |
dc.identifier.citedreference | Frew JW, Navrazhina K, Marohn M, Lu CP, Krueger JG. Contribution of fibroblasts to tunnel formation and inflammation in hidradenitis suppurativa/Acne Inversa. Exp Dermatol. 2019; 28 ( 8 ): 1 - 6. | |
dc.identifier.citedreference | Freysz M, Jemec GB, Lipsker D. A systematic review of terms used to describe hidradenitis suppurativa. Br J Dermatol. 2015; 173 ( 5 ): 1298 - 1300. | |
dc.identifier.citedreference | Otberg N, Richter H, Schaefer H, Blume- Peytavi U, Sterry W, Lademann J. Variations of hair follicle size and distribution in different body sites. J Invest Dermatol. 2004; 122 ( 1 ): 14 - 19. | |
dc.identifier.citedreference | Vogt A, Hadam S, Heiderhoff M, et al. Morphometry of human terminal and vellus hair follicles. Exp Dermatol. 2007; 16 ( 11 ): 946 - 950. | |
dc.identifier.citedreference | Lu C, Fuchs E. Sweat gland progenitors in development, homeostasis, and wound repair. Cold Spring Harb. Perspect Med. 2014; 4 ( 2 ): a015222. | |
dc.working.doi | NO | en |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.